Oliver Tracie
- SEC CIK
- 0001935706
No open-market purchases or sales filed in the past year.
Current role at each company
- ARWR Arrowhead Pharmaceuticals, Inc.Chief Commercial Officeras of Jul 3, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Oliver Tracie as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 3, 2024 (view filing) | Jul 2 | 1 day | Oliver TracieChief Commercial Officer | SSale | −9.39K | $25.28 | −$237.5K | −6.9%127.1K after | 10b5-1 |
| Jan 8, 2024 (view filing) | Jan 5 | 3 days | Oliver TracieChief Commercial Officer | SSale | −74 | $33.89 | −$2.51K | −0.1%136.5K after | 10b5-1 |
| Jul 6, 2023 (view filing) | Jul 3 | 3 days | Oliver TracieChief Commercial Officer | SSale | −8.93K | $35.31 | −$315.1K | −12.7%61.6K after |